Premium
Comparison of perioperative outcomes in robot‐assisted radical cystectomy and laparoscopic radical cystectomy
Author(s) -
Zhang Shiwei,
Lin Tingsheng,
Zhang Qing,
Zhang Shengjie,
Liu Guangxiang,
Ji Changwei,
Guo Hongqian
Publication year - 2020
Publication title -
the international journal of medical robotics and computer assisted surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.556
H-Index - 53
eISSN - 1478-596X
pISSN - 1478-5951
DOI - 10.1002/rcs.2074
Subject(s) - cystectomy , perioperative , medicine , bladder cancer , complication , surgery , laparoscopy , urology , cancer
Objective To report perioperative outcomes in robot‐assisted radical cystectomy and laparoscopic radical cystectomy. Patients and Methods Between January 2010 and July 2019, 298 patients with bladder cancer underwent robotic‐assisted radical cystectomy (RARC) (n = 172) and laparoscopic radical cystectomy (LRC) (n = 126) at our institution were enrolled in the retrospective study. The demographic, perioperative, and complication data were collected and analyzed. Results The RARC group had less operative duration ( P < .001), less blood loss ( P < .001), lower transfusion rate ( P < .05), and shorter hospital stay ( P < .001) than the LRC group. The 90‐day readmission rate between the RARC and LRC group had no significant differences ( P = .401). The 90‐day overall complication rates in the RARC group was much lower than the LRC group ( P = .009). The 90‐day minor complication rates (Clavien‐Dindo grade ≤ IIA) between the RARC and LRC groups were similar ( P = .274). The 90‐day major complication rates (Clavien‐Dindo grade ≥ IIIA) in the LRC group was higher than the RARC group ( P = .022). Conclusions The RARC approach appears to offer some operative and perioperative benefits compared with the LRC approach. Larger, randomized studies are required to confirm these findings.